FOXP3 and relapsing-remitting multiple sclerosis: According to Venken et al. [8], the expression of Foxp3 and the numbers of peripheral CD4+CD25+ Foxp3+ T cells significantly decrease in relapsing-remitting MS patients compared with those in control subjects.